tiprankstipranks
Livzon Pharmaceutical Group Inc Class H (LVZPF)
OTHER OTC:LVZPF

Livzon Pharmaceutical Group (LVZPF) Stock Forecast & Price Target

4 Followers
See the Price Targets and Ratings of:

LVZPF Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Livzon
Pharmaceutical Group
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

LVZPF Stock 12 Month Forecast

There Are No Analyst Ratings for LVZPF In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

LVZPF Financial Forecast

LVZPF Earnings Forecast

Next quarter’s earnings estimate for LVZPF is $0.08 with a range of $0.07 to $0.09. The previous quarter’s EPS was $0.05. LVZPF beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.48% of the time in the same period. In the last calendar year LVZPF has Underperformed its overall industry.
Next quarter’s earnings estimate for LVZPF is $0.08 with a range of $0.07 to $0.09. The previous quarter’s EPS was $0.05. LVZPF beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.48% of the time in the same period. In the last calendar year LVZPF has Underperformed its overall industry.

LVZPF Sales Forecast

Next quarter’s sales forecast for LVZPF is $463.70M with a range of $463.70M to $463.70M. The previous quarter’s sales results were $378.13M. LVZPF beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.18% of the time in the same period. In the last calendar year LVZPF has Underperformed its overall industry.
Next quarter’s sales forecast for LVZPF is $463.70M with a range of $463.70M to $463.70M. The previous quarter’s sales results were $378.13M. LVZPF beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.18% of the time in the same period. In the last calendar year LVZPF has Underperformed its overall industry.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
HSBC
$4.47
Buy
39.67%
Upside
Upgraded
01/17/24
HSBC Upgrades Livzon Pharmaceutical Group Inc. (1513:HK) (LVZPF) to BuyHSBC analyst Linda Shu upgraded Livzon Pharmaceutical Group Inc. (1513:HK) (OTC: LVZPF) from Hold to Buy with a price target of HK$35.00 (from HK$28.00).
Citi
$4.49
Buy
40.47%
Upside
Reiterated
10/27/23
Livzon Pharmaceutical Group Inc. (1513:HK) (LVZPF) PT Lowered to HK$35.20 at CitiCiti analyst Cui Cui lowered the price target on Livzon Pharmaceutical Group Inc. (1513:HK) (OTC: LVZPF) to HK$35.20 (from HK$36.60) while maintaining a Buy rating.
Morgan Stanley
$2.55
Sell
-20.19%
Downside
Reiterated
09/08/23
Livzon Pharmaceutical Group Inc. (1513:HK) (LVZPF) PT Lowered to HK$20 at Morgan StanleyMorgan Stanley analyst Sean Wu lowered the price target on Livzon Pharmaceutical Group Inc. (1513:HK) (OTC: LVZPF) to HK$20.00 (from HK$21.60) while maintaining a Underweight rating.

Best Analysts Covering Livzon Pharmaceutical Group

Which Analyst Should I Follow If I Want to Buy LVZPF and Sell After:
1 Month
Success Rate
1/2 ratings generated profit
50%
Average Return
+1.35%
reiterated a buy rating 6 months ago
Copying Cui Cui's trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of +1.35% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
3 Months
Sean Wu CFAMorgan Stanley
Success Rate
2/3 ratings generated profit
67%
Average Return
+3.43%
reiterated a sell rating 8 months ago
Copying Sean Wu CFA's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +3.43% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
1 Year
Sean Wu CFAMorgan Stanley
Success Rate
2/3 ratings generated profit
67%
Average Return
+2.97%
reiterated a sell rating 8 months ago
Copying Sean Wu CFA's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +2.97% per trade.
2 Years
Sean Wu CFAMorgan Stanley
Success Rate
2/3 ratings generated profit
67%
Average Return
+4.70%
reiterated a sell rating 8 months ago
Copying Sean Wu CFA's trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +4.70% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

LVZPF Analyst Recommendation Trends

Rating
Dec 21
Sep 22
Sep 23
Oct 23
Jan 24
Strong Buy
2
1
0
1
2
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
1
2
3
2
1
Strong Sell
0
0
0
0
0
total
3
3
3
3
3
In the current month, LVZPF has received 2 Buy Ratings, 0 Hold Ratings, and 1 Sell Ratings. LVZPF average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

LVZPF Stock Forecast FAQ

What is LVZPF’s average 12-month price target, according to analysts?
Currently, no data Available
What is LVZPF’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for LVZPF, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is LVZPF a Buy, Sell or Hold?
      Currently, no data Available
      What is Livzon Pharmaceutical Group Inc Class H’s price target?
      Currently, no data Available
      What do analysts say about Livzon Pharmaceutical Group Inc Class H?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of LVZPF?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis